NASDAQ Companies

Fortified Balance Sheet of $113.0 Million Enables Company to continue R&D activities in AI-Driven Customer Platform in other Corporate Initiatives […]

MELVILLE, N.Y., March 20, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage […]

Advancement of oral, brain-penetrant NLRP3 inhibitor BGE-102, with initial clinical data expected 2H25 Progression of preclinical next-generation APJ agonists for […]

WALTHAM, Mass., March 20, 2025 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on advancing life-transforming […]

CTIM-76 first patient dosed in January 2025 Cash and cash equivalents of $94.4 million as of December 31, 2024 Company […]

CTIM-76 first patient dosed in January 2025 Cash and cash equivalents of $94.4 million as of December 31, 2024 Company […]

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) — ExlService Holdings, Inc. (NASDAQ: EXLS), a global data and AI company, today […]

Geneva, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) — Schedules Conference Call and Webcast for Monday, March 24 at 10:00 am […]

Geneva, Switzerland, March 20, 2025 (GLOBE NEWSWIRE) — Schedules Conference Call and Webcast for Monday, March 24 at 10:00 am […]

LOS ANGELES, March 20, 2025 (GLOBE NEWSWIRE) — PLBY Group, Inc. (Nasdaq: PLBY) (the “Company” or “PLBY Group”), a leading […]